August 2, 2022
The University of Cincinnati's Jiajie Diao, PhD, and colleagues have published new research in the journal Nature Communications showing light-activated proteins can help normalize dysfunction within cells.
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
May 8, 2023
The University of Cincinnati's Jiajie Diao and Yujie Sun led recently published research showing the use of a new cellular probe helped discover new findings about certain cellular processes.
January 17, 2024
The University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska, MD, PhD, has been awarded a five-year, $2.8 million grant from the National Institutes of Health to investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.
January 10, 2023
Krushna Patra is the first University of Cincinnati researcher to receive the prestigious National Cancer Institute MERIT Award to continue his research on how mutations help pancreatic cancer grow.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
October 16, 2023
A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.